NCT01144962
Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease
Phase: Phase 1/2
Role: Collaborator
Start: Jun 30, 2010
Completion: Dec 31, 2014